MedTrace Logo

Acute Medium Chain Triglycerides (MCT) Intake in Young and Older Participants

NCT03830268 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-03-25

No results posted yet for this study

Summary

Compare plasma metabolites following different conditions paired with a dietary MCT beverage over an 8-hour metabolic day protocol in young and older participants.

Conditions

  • Ketonemia

Interventions

DIETARY_SUPPLEMENT

No MCT intake with breakfast, no lunch

Water given with a regular standardize breakfast and water given at noon without lunch.

DIETARY_SUPPLEMENT

No MCT intake with lunch, no breakfast

Water given in the beginning of the metabolic study day without breakfast and water given at noon with a regular standardize lunch.

DIETARY_SUPPLEMENT

10g of Betaquik

BQ10 given with a regular standardize breakfast and BQ10 given at noon without lunch.

DIETARY_SUPPLEMENT

10g of Betaquik with low-carbs breakfast

BQ10 given with a low-carbs standardize breakfast and BQ10 given at noon without lunch.

DIETARY_SUPPLEMENT

20g of Betaquik

BQ20 given with a regular standardize breakfast and BQ20 given at noon without lunch.

DIETARY_SUPPLEMENT

10g of Betaquik with lunch, no breakfast

BQ10 given in the beginning of the metabolic study day without breakfast and BQ10 given at noon with a regular standardize lunch.

Sponsors & Collaborators

  • Université de Sherbrooke

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-02
Primary Completion
2019-06-25
Completion
2019-06-25

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03830268 on ClinicalTrials.gov